Companies / PIQ

PROTEOMICS INTERNATIONAL LABORATORIES LTD

ASX:PIQPharmaceuticals, Biotechnology & Life Sciences
165.4M shares on issueASX (delayed) · snapshot 11 Sept 2026179.3M fully diluted+8.4% if every option and right converts$0.14price · delayed$23.2Mmarket cap · indicative

Today’s holders own 92.3% of what they think they own, once every option and right converts.

Moderate
Dilution risk

Runway under 2 quarters; share count grew 26% in 24 months; 1 cash raise in 24 months

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway0.9 quarters of funding
Share-count growth (24m)26.2%
Raise cadence (24m)1 cash raise
Options & rights overhang8.4% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

PROTEOMICS INTERNATIONAL LABORATORIES LTD's ordinary share count grew 26.2% between July 2024 and July 2026, reaching 165M shares. The company undertook one capital raise in the past 24 months, a A$12.0M placement and Share Purchase Plan in April 2025. Options and rights on issue could convert into 14M new shares, representing 8.4% of the current share count, with the nearest expiry in November 2026; none are currently in the money. At the June 2026 quarter end, the company held A$1.8M in cash, sufficient for approximately 0.9 quarters of operations. No proposed securities issues are currently pending.

AI-generated summary of this page's cited filings · updated 10 Sept 2026
Get told when this changes
Set up alerts
Daily email alerts cover risk-level moves, new raises, pending proposed issues and option expiries for the companies you follow.
8.4%
Options & rights overhang
0.0%
In-the-money supply
0
Raises · last 12 months
0.9 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 165.4M per ASX (delayed) (snapshot 11 Sept 2026).
130M140M150M160MDec 24Oct 25Sept 26Cash raise · 15 Apr 2025165.4M

Cash runway

0.9 qtrs
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
The latest quarterly report funded operations to about Sept 2026 — that date has passed, and no later report is on record.
$1.8M cash after burn from the quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds. Filed with the quarterly report: $3.5M cash at quarter end (item 4.6), 1.7 qtrs of funding on the company’s own estimate. Our figure above carries the filed quarter-end balance forward at the reported spend rate and adds announced raise proceeds.
Free account
15 quarters on record — Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
12 July 20262A · quoted issuePIQ : ORDINARY FULLY PAID165.4MAppendix 2A
6 July 20263H · cancellationPIQ : ORDINARY FULLY PAID165.2MAppendix 3H
2 June 20262A · quoted issuePIQ: ORDINARY FULLY PAID165.2MAppendix 2A
1 Feb 20262A · quoted issuePIQ : ORDINARY FULLY PAID165.2MAppendix 2A
21 Jan 20262A · quoted issuePIQ : ORDINARY FULLY PAID165.1MAppendix 2A
Free account
35 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Capital raises

1 cash raise in the last 24 months · 0 in the last 12 months

$12.0M
Placement and Share Purchase Plan (SPP)
15 Apr 2025
Free account
3 raises on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account
12 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.

About 99% of the 15% placement capacity left — about 1% used by Appendix 3B filings in the last 12 months (estimate, as at 2026-09-12). Holder-approved issues and any later ratification are not deducted, so the true headroom can be higher.
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

8.4%
Options & rights overhang · of current shares
0.0%
In-the-money supply · at current price
13.9M
Potential new shares
Nov 2026
Nearest expiry
What this supply is, and what converts it
  • Price-triggered13.7M · 8.3% of shares
    Options and warrants — they convert when the share price clears their exercise price.
  • Condition-triggered205k · 0.1% of shares
    Performance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.

Exercise price on record: 13.7M priced, 205k where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.

Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.

What a price move would switch on
6.9M13.9M$0.14 now0.25× today ($0.04) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($0.07) — 0 of the priced supply in the money, 0.0% of shares on issue0.75× today ($0.11) — 0 of the priced supply in the money, 0.0% of shares on issue1× today ($0.14) — 0 of the priced supply in the money, 0.0% of shares on issue1.25× today ($0.18) — 0 of the priced supply in the money, 0.0% of shares on issue1.5× today ($0.21) — 0 of the priced supply in the money, 0.0% of shares on issue2× today ($0.28) — 0 of the priced supply in the money, 0.0% of shares on issue3× today ($0.42) — 0 of the priced supply in the money, 0.0% of shares on issue5× today ($0.70) — 2.6M of the priced supply in the money, 1.6% of shares on issue10× today ($1.40) — 3.2M of the priced supply in the money, 1.9% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

At $0.14 today, 0 securities are in the money (0.0% of shares on issue). No more priced supply until 5× today’s price, which takes it to 2.6M (1.6% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
  • 205k (1.5% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
  • 10.5M more carries an exercise price above ten times today’s — off the right of this axis, and in every total on this page.
CodeSecurityTypeExercise priceExpiryOn issueSource
PIQAAAOptionsPrice-triggered$1.7624 Nov 2026375kFiling
PIQAAKOptionsPrice-triggered$0.566 June 20272.4MFiling
PIQAAIOptionsPrice-triggered$1.2030 June 2027300kFiling
PIQAABOptionsPrice-triggered$1.5030 June 20271.8MFiling
PIQAACOptionsPrice-triggered$2.5030 June 20271.1MFiling
PIQAAFOptionsPrice-triggered$1.5021 Nov 20271.1MFiling
PIQAADOptionsPrice-triggered$3.5030 June 2028728kFiling
PIQAAEOptionsPrice-triggered$5.0030 June 20283.6MFiling
PIQAAGOptionsPrice-triggered$2.5021 Nov 2028925kFiling
PIQAAHOptionsPrice-triggered$3.5021 Nov 2028800kFiling
PIQAALOptionsPrice-triggered$0.6725 Nov 2028250kFiling
PIQAAMOptionsPrice-triggered$1.0025 Nov 2029250kFiling
PIQAYPerformance rightsCondition-triggered——205kFiling Meeting

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.

A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.

Free account
13 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
26 Nov 2025Aaron BrinkworthOther135k135k——3Y notice
26 Nov 2025Vicki RobinsonOther—250k——3Y notice
25 Nov 2025Neville GardinerSell199k250k——3Y notice
Free account
7 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

31 Aug 2026$PAppendix 4E and Annual Report
31 Aug 2026Appendix 4G and Corporate Governance Statement
12 Aug 2026$PAustralian patent for PromarkerEndo
4 Aug 2026Change in substantial holding
26 July 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
22 July 2026Webinar Presentation - Healius distribution agreement
21 July 2026$PProteomics signs national distribution deal with Healius
12 July 2026Application for quotation of securities - PIQ
8 July 2026$PUS patent secured for PromarkerEndo
6 July 2026Notification of cessation of securities - PIQ
3 July 2026$PResponse to ASX Price Query
2 July 2026Change of Registered Office Address
2 June 2026Application for Quotation of Securities - PIQ
7 May 2026$PResponse to ASX Price Query
1 May 2026Notification of Expiry of Listed Options - PIQO
27 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
27 Apr 2026$PProteomics Strategic Plan
17 Apr 2026Final Director's Interest Notice
16 Apr 2026$PRestructure, Executive Appointment and Board Update
24 Feb 2026$PAppendix 4D and Interim Financial Report

Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.